Myriad Genetics Inc. (MYGN): Today's Featured Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Myriad Genetics ( MYGN) pushed the Services sector lower today making it today's featured Services laggard. The sector as a whole closed the day up 1.3%. By the end of trading, Myriad Genetics fell $0.72 (-2.3%) to $30.57 on light volume. Throughout the day, 1,514,133 shares of Myriad Genetics exchanged hands as compared to its average daily volume of 2,310,100 shares. The stock ranged in price between $29.95-$31.14 after having opened the day at $31.13 as compared to the previous trading day's close of $31.29. Other companies within the Services sector that declined today were: Ambassadors Group ( EPAX), down 16.9%, Blue Nile ( NILE), down 15.1%, Lentuo International ( LAS), down 14.0% and Roadrunner Transportation Systems ( RRTS), down 13.2%.

Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States. Myriad Genetics has a market cap of $2.0 billion and is part of the diversified services industry. Shares are up 49.1% year to date as of the close of trading on Wednesday. Currently there are 4 analysts that rate Myriad Genetics a buy, 2 analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Myriad Genetics as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the positive front, Monster Worldwide ( MWW), up 22.9%, Maximus ( MMS), up 19.6%, Lee ( LEE), up 13.7% and Advance Auto Parts ( AAP), up 12.7% , were all gainers within the services sector with Twenty-First Century Fox ( FOXA) being today's featured services sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the services sector could consider iShares Dow Jones US Cons Services ( IYC) while those bearish on the services sector could consider ProShares Ultra Short Consumer Sers ( SCC).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Biotech Movers: Jazz Shares Lower Amid Notes Offering

Biotech Movers: Myriad Genetics, Spectrum Pharmaceuticals, Array BioPharma

Bullish and Bearish Reversals in the Market

Biotech Premarket Movers: Sage Therapeutics, Immunomedics, Myriad Genetics

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments